Skip to main content

Table 1 Factors associated with delayed ART/antiretroviral prophylaxis initiation among women diagnosed with HIV during their current pregnancy

From: Initiation of antiretroviral therapy or antiretroviral prophylaxis in pregnant women living with HIV registered in five townships of Mandalay, Myanmar: A cross sectional study

Description

total

col %

delay¥

row %

PR (95% CI)

aPR(95% CI)

Total

180

 

109

61%

  

age group

  < =20

9

5%

5

56%

1

 

 21–30

112

62%

66

59%

1.1 (0.6–1.9)

 

  > =31

59

33%

38

64%

1.2 (0.6–2.1)

 

township

 Township 1

11

6%

2

18%

1

1

 Township 2

63

35%

37

59%

3.2 (0.9–11.5)

3.6 (0.8–15.5)

 Township 3

16

9%

6

38%

2.1 (0.5–8.4)

2.4 (0.5–11.8)

 Township 4

58

32%

43

74%

4.1 (1.1–14.5)*

4.2 (1.2–14.8)*

 Township 5

32

18%

21

66%

3.6 (1.0–13.0)

3.6 (1.0–13.0)

CD4 count

  < 350

100

56%

64

64%

1.1 (0.9–1.5)

 

  ≥ 350

73

41%

41

56%

1

 

 Missing

7

4%

4

57%

  

WHO staging

 Stage I/II

154

86%

91

59%

1

 

 Stage III/IV

15

8%

11

73%

1.2 (0.9–1.7)

 

 Missing

11

6%

7

64%

  

Occupation

 Yes

63

35%

38

60%

1

 

 No

87

48%

53

61%

1 (0.8–1.3)

 

 Missing

30

17%

18

60%

  

Distance

  ≤6 km

69

38%

36

52%

1

1

  > 6 km

100

56%

66

66%

1.3 (1–1.7)

1.2 (0.5–2.5)

 Missing

11

6%

7

64%

  
  1. ART/antiretroviral prophylaxis Antiretroviral therapy/Antiretroviral prophylaxis, col% column percentage, PR prevalence ratio, 95% CI 95% confidence interval, aPR adjusted prevalence ratio, ¥ delay initiation of ART/antiretroviral prophylaxis, km kilometer, *p value< 0.05, p-value < 0.2 were included in adjusted analysis, Delayed intiation of ART/antiretroviral prophylaxis = more than 2 week from date of HIV dagnosis.